SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.9 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. This part of our website provides a brief summary of each portfolio company with links to their websites where possible.